Your doctor will choose the best cholesterol-lowering drug for you based on your cholesterol numbers, medical history, side effects, personal preferences, and insurance coverage
We always have a way to meet and exceed our customers expectations
(2018) 20 Suppl 1:2233
The search strategy for each database used the following terms: GLP-1 AND anesthesia, GLP-1 AND anesthesiology", GLP-1 AND aspiration, GLP-1 AND gastric emptying, GLP-1 AND gastric content, GLP-1 AND gastric residual, GLP-1 AND perioperative, GLP-1 AND surgical consideration, and GLP-1 AND surgical assessment" ( Supplemental File 1 )
Semaglutide was selected for Medicare drug price negotiation in 2025, with a negotiated price set to take effect in 2027 but that negotiated price applies to diabetes and cardiovascular indications covered under current Medicare statute, not to obesity, which remains statutorily excluded
JAMA Internal Medicine, 184 (9), 10561064